Solid Biosciences Inc. · NASDAQ:SLDB
Vestal Point Capital, LP's stake in Solid Biosciences Inc. fell to 4.80% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Vestal Point Capital, LP's stake in Solid Biosciences Inc. fell to 4.80%, 4,833,796 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.80%
- Shares
- 4,833,796
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 4.80% | 4,833,796 |
| Ryan Wilder | 4.80% | 4,833,796 |
Source
Related
- Solid Biosciences Inc.
- Vestal Point Capital, LP
- Solid Biosciences Inc. shareholders
- Schedule 13G · Vestal Point Capital, LP · Feb 17, 2026
- Schedule 13G/A · Vestal Point Capital, LP · May 15, 2025
- Form 4 · Brooks Gabriel · Oct 20, 2026
- Form 4 · Smith Ian F · Oct 6, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026